These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 5030802)
1. Treatment of malignant melanoma with camptothecin (NSC-100880). Gottlieb JA; Luce JK Cancer Chemother Rep; 1972 Feb; 56(1):103-5. PubMed ID: 5030802 [No Abstract] [Full Text] [Related]
2. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811 [No Abstract] [Full Text] [Related]
3. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma]. Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U Tumori; 1973; 59(3):239-48. PubMed ID: 4729646 [No Abstract] [Full Text] [Related]
4. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). Gottlieb JA; Guarino AM; Call JB; Oliverio VT; Block JB Cancer Chemother Rep; 1970 Dec; 54(6):461-70. PubMed ID: 4946015 [No Abstract] [Full Text] [Related]
5. Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma. Gottlieb JA; Frei E; Luce JK Cancer Chemother Rep; 1971 Jun; 55(3):277-80. PubMed ID: 5115848 [No Abstract] [Full Text] [Related]
6. Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda. Vogel CL; Comis R; Ziegler JL; Kiryabwire JW Cancer Chemother Rep; 1971 Apr; 55(2):143-9. PubMed ID: 5118684 [No Abstract] [Full Text] [Related]
7. Phase II study of 6 -methylpregn-4-ene-3,11,20-trione (NSC-17256). Ramirez G; Weiss AJ; Rochlin DB; Bisel HF Cancer Chemother Rep; 1971 Jun; 55(3):265-8. PubMed ID: 5115847 [No Abstract] [Full Text] [Related]
8. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma. Falkson G; Van der Merwe AM; Falkson HC Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061 [No Abstract] [Full Text] [Related]
9. [1st experiences in the treatment of ovarian tumors with Peptichemio]. Natale N; Mangioni C; Remotti G Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233 [No Abstract] [Full Text] [Related]
11. [Use of auratin in the complex therapy of melanomas]. Zolotkov AG; Nivinskaia MM; Parshikova SM; Paches LR Antibiotiki; 1970 Dec; 15(12):1111-6. PubMed ID: 4100474 [No Abstract] [Full Text] [Related]
12. Ukrain with chemotherapy in malignant melanoma (case report). Stabuc B; Benedicic D Drugs Exp Clin Res; 1996; 22(3-5):231-3. PubMed ID: 8899337 [TBL] [Abstract][Full Text] [Related]
13. Toxicity of camptothecin (NSC-100880). Schaeppi U; Fleischman RW; Cooney DA Cancer Chemother Rep 3; 1974 Sep; 5(1):25-36. PubMed ID: 4213507 [No Abstract] [Full Text] [Related]
14. [Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate]. Schubert JC; Martin H Munch Med Wochenschr; 1968 Jan; 110(2):97-100. PubMed ID: 5695132 [No Abstract] [Full Text] [Related]
15. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma. Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016 [No Abstract] [Full Text] [Related]
17. [Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer]. Zhu WG; Yu CH; Li T Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):525-6. PubMed ID: 22093631 [No Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis. Cao J; Qi F; Liu T Scand J Gastroenterol; 2014 Jun; 49(6):690-704. PubMed ID: 24731211 [TBL] [Abstract][Full Text] [Related]
20. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma. Kingra GS; Comis R; Olson KB; Horton J Cancer Chemother Rep; 1971 Jun; 55(3):281-3. PubMed ID: 5115849 [No Abstract] [Full Text] [Related] [Next] [New Search]